Syndromic management of prolonged fever: a cost-effective approach.
Daga
S R
SR
Cama and Albless Hospital, Mumbai, India. subhashdaga@yahoo.com
Patil
V B
VB
Verma
Bela
B
D000890:Anti-Infective Agents / Q000191:economics* / Q000627:therapeutic use; D000962:Antimalarials / Q000191:economics* / Q000627:therapeutic use; D002701:Chloramphenicol / Q000191:economics / Q000627:therapeutic use; D002738:Chloroquine / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D005334:Fever / Q000191:economics / Q000628:therapy*; D006801:Humans; D007223:Infant; D015767:Mefloquine / Q000191:economics / Q000627:therapeutic use; D013997:Time Factors; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000191:economics / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000962:Antimalarials; D002701:Chloramphenicol; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D002738:Chloroquine; D015767:Mefloquine